Coronavirus BRIEFING
Supported by Essilor

The Latest COVID-19 Data

Changing Entrenched Health Beliefs Is Not Impossible

By Staff
Friday, May 24, 2024 6:00 AM Turns out it’s not a Sisyphean task—or at least not impossible, like trying to roll a large boulder up a steep hill over and over again. Some people with deep-rooted beliefs on a wide range of health topics—from COVID vaccination to mental health stigma to foods including genetically modified organisms—could be persuaded to rethink their positions.

The National Average for Gross Revenue at ECP Locations Increased for the Week of May 13–19, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Wednesday, May 22, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations increased last week, May 13–19, when compared with the previous week at a rate of 4 index points. That places gross revenue at a level 9 index points above where it was at this point in time (Week 20) when compared with last year (2023), 13 points above the same period in 2022, 20 points above 2021, 55 points above 2020 (during COVID) and 25 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

COVID Symptoms to Look Out For

By Staff
Monday, May 20, 2024 12:30 PM Warmer weather is approaching, and there is a new dominant COVID variant in the United States. Head over to HuffPost for a look at the most common symptoms related to this variant, so you can keep yourself and others safe. 

The National Average for Gross Revenue at ECP Locations Remained Flat for the Week of May 6–12, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Monday, May 20, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations remained flat last week, May 6–12, when compared with the previous week. That places gross revenue at a level 3 index points above where it was at this point in time (Week 19) when compared with last year (2023), 7 points above the same period in 2022, 14 points above 2021, 69 points above 2020 (during COVID) and 20 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

More Americans Move Out of Metro Areas Post COVID-19

By Staff
Friday, May 17, 2024 3:53 PM The COVID-19 pandemic pushed more Americans out of urban areas, according to a new report from the U.S. Census Bureau. New data shows that Americans are choosing to move out of metro areas, as far as 60 miles away, particularly to areas defined as exurb or outer margins of cities.

A wide range of factors are driving the exodus from cities, according to the Census Bureau, including rising housing costs following the pandemic, and more opportunities to work from home, removing the need for commuting to the office.

New population analysis shows the fastest-growing cities in the U.S. were not in metro areas—the highest collective gains in population happened in regions 20 miles outside of urban areas.

The Phoenix-Masa-Chandler region in Arizona experienced one of the biggest surges, taking the number 10 spot for largest metro areas in the U.S. with a population of 5 million residents.

Growth in Phoenix fell from 1.6 percent to 0.4 percent, however, areas on the outside of the city saw significant increases including in Maricopa which grew by just over 7 percent in 2023, compared to 4.2 percent from 2018-2019.

Experts at the Census Bureau are unsure if this is a temporary phenomenon or a sign of future migration patterns.

Spring and Summer COVID

By Staff
Friday, May 10, 2024 1:05 PM Doctors and researchers are closely watching a new COVID variant called KP.2, monitoring what its spread might mean for the Spring and Summer seasons. Head over to The New York Times for more. 

The National Average for Gross Revenue at ECP Locations Decreased for the Week of April 29–May 5, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Thursday, May 9, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, April 29–May 5, when compared with the previous week at a rate of -1 index point. That places gross revenue at a level 3 index points above where it was at this point in time (Week 18) when compared with last year (2023), 10 points above the same period in 2022, 14 points above 2021, 93 points above 2020 (during COVID) and 23 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

New Data on COVID Vaccines and New-Onset Seizures

By Staff
Wednesday, May 8, 2024 8:02 AM There is no association between the SARS-CoV-2 vaccine and the risk for new-onset seizure, data from a new meta-analysis of six randomized, placebo-controlled clinical trials (RCTs) showed.

Thousands Believe COVID Vaccines Harmed Them

By Staff
Tuesday, May 7, 2024 6:09 AM Thousands of Americans believe they suffered legitimate injuries from COVID vaccines but say they've been ignored and dismissed. Click here to read the full story.

WHO Overturns Dogma on Airborne Disease Spread; the CDC Might Not Act on It

By Staff
Monday, May 6, 2024 6:09 AM The World Health Organization has issued a report that transforms how the world understands respiratory infections like covid-19, influenza, and measles.

COVID Viral Loads Decreased With Metformin, Study Shows

By Staff
Friday, May 3, 2024 6:09 AM SARS-CoV-2 viral loads were sharply decreased with metformin, according to a placebo-controlled trial. Click here to read the full story.

New mRNA Vaccines in Development for Cancer and Infections

By Staff
Friday, May 3, 2024 6:02 AM BERLIN—To date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many other potential applications for this vaccine technology, which suggests a promising future. Martina Prelog, MD, a pediatric and adolescent medicine specialist at the University Hospital of Würzburg in Germany, reported on the principles, research status, and perspectives for these vaccines at the 25th Travel and Health Forum of the Center for Travel Medicine in Berlin.

The National Average for Gross Revenue at ECP Locations Decreased for the Week of April 22–28, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Friday, May 3, 2024 12:27 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, April 22–28, when compared with the previous week at a rate of -2 index points. That places gross revenue at a level 5 index points above where it was at this point in time (Week 17) when compared with last year (2023), 11 points above the same period in 2022, 14 points above 2021, 102 points above 2020 (during COVID) and 19 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

Flu vs COVID: Stark Disparity in Vaccination and Deaths

By Staff
Thursday, May 2, 2024 8:02 AM In the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed about half that amount. Yet half as many people received the updated COVID booster as those who got the flu shot—even though COVID is twice as deadly as influenza.

Association of New-Onset Seizures With SARS-CoV-2 Vaccines

By Staff
Wednesday, May 1, 2024 6:09 AM The incidence of new-onset seizures was not significantly different between SARS-CoV-2 vaccine recipients and placebo recipients, a meta-analysis of clinical trial data showed, according to JAMA Neurology.